Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 196

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Psoas as a sentinel muscle for sarcopenia: a flawed premise

Open access
Baracos, Vickie E.·2017·Journal of Cachexia, Sarcopenia and Muscle

Abstract

Loss of mass and functional capacity of skeletal muscle is a major cause of morbidity in older individuals as well as in patients affected by a host of acute and chronic conditions including infectious disease, endocrine and metabolic disorders, organ dysfunction, immunological disease, vascular diseases, haematological disorders, and malignancies. Quantitative approaches are required to diagnose and study this muscle loss, and these are represented in the literature predominantly by dual energy X-ray (DXA), computed tomography (CT), and magnetic resonance imaging.1 Total appendicular skeletal muscle by DXA has been considered the standard quantitative measure1 and appears in nearly 500 publications. The application of CT has recently been popularized in patients who had an indication for CT scan as part of their standard medical care. The methods cited above are subject to the limitation that they are not typically amenable to the quantification of whole body muscle mass, for different reasons. DXA is limited to muscle in the limbs, and clinical CT scans are rarely of the whole body. Within these restrictions, effort is taken to measure as much, if not all of the muscle, to fully represent this organ system. Literature on sarcopenia does not focus on specific individual muscles, rather the systemic loss of muscle, and its impact on overall function2, 3 is highlighted. While the CT approach is not yet set to internationally accepted standards, the majority of researchers adopted quantification of total lumbar muscle cross-sectional area (CSA) because this region is the object of diagnostic imaging in multiple illnesses and this area of the body includes a diverse representation of muscles (psoas, erector spinae, quadratus lumborum, transverse abdominis, external and internal obliques, and rectus abdominus). Lumbar muscle area is also reasonably well correlated with whole body muscle mass.4, 5 A single-muscle approach to the diagnosis of clinically important depletion of skeletal muscle is a recent trend in the literature on CT-defined muscle quantification. The single muscle is most often the psoas major and occasionally adductor pollicis, pectoralis, or masseter. Single muscle studies represent a minority (~6%) of quantitative studies of muscle mass, and the vast majority of scholarly works on sarcopenia does not contain any suggestion that a single muscle would serve as a sentinel. The premise that psoas should be selected over all other individual muscles, muscle groups, and total muscle mass has not been discussed in the literature nor has any validation been conducted. The choice of psoas is merely stated to be ‘simple and convenient’6 to measure. The article by Rutten et al. in this edition of JCSM7 provides a quantitative comparison of total lumbar muscle area with the psoas area. Data are from patients with ovarian cancer, but the findings may have broader implication. The weaknesses that these authors observe for the psoas-only approach include its very low proportion of total trunk muscles (<10%), high measurement error, and weak correlation of psoas area with total lumbar muscle area. Psoas area change over time showed a large variance and was unrelated to the clinical outcome of overall survival. A method of imputation of psoas area from measures of its length and width was particularly disastrous in terms of its poor correlation with psoas area and the high inconsistency of measures between observers. This muscle is not symmetrical in shape, and such methods would seem unlikely to be reliable. By a variety of quantitative indices, psoas failed all tests of technical and clinical merits for the assessment of systemic muscle wasting in this patient population. A rabble of disparate measurements and reporting is found in the publications concerning psoas muscle sarcopenia. Psoas is represented variously by its unidimensional thickness, its CSA in unadjusted cm2, CSA normalized to patient height2, CSA normalized to body surface area, or CSA normalized to the area of the adjacent vertebral body; occasionally, the volume of the entire muscle has been reported. Psoas area is often measured at a standard lumbar vertebral landmark (L3 or L4), but sometimes, unreliable soft tissue landmarks such as the umbilicus have been used. The literature contains no justification (or reconciliation) of these disparate approaches. The resulting data cannot be aggregated, nor can it be compared with the larger literature in which the accepted basis for normalization of muscle mass is by the individual subject's height2. Quantitative data on psoas have been related to a variety of clinical outcomes, with the overall concept that some threshold for low psoas amount would predict morbidity or mortality; however, because such threshold values are reported in disparate units of measure, no general conclusions can be reached. Muscles have specific functions. Psoas is the main flexor of the hip and also provides postural sup

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcsm.12221

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 196

Metadata

Authors
Baracos, V. E.
Venue
Journal of Cachexia, Sarcopenia and Muscle
Publisher
Wiley
Published
2017-07-03
Volume
8
Issue
4
Pages
527-528
ISSN
  • 2190-5991 (ISSN-L)
  • 2190-6009
OpenAlex
W2732691119
Cited by
196
References
1
FWCI
12.53
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Psoas as a sentinel muscle for sarcopenia: a flawed premise. https://app.cochat.ai/papers/10.1002/jcsm.12221
The paper
Baracos, V. E. (2017). Psoas as a sentinel muscle for sarcopenia: a flawed premise. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.12221

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.